These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36371467)

  • 21. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.
    Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A
    Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse Drug Reactions Involving Protein Kinase Inhibitors: A French Pharmacovigilance Database Study Comparing Safety in Younger and Older Patients (≥ 75 years) with Cancer.
    Clapes V; Rousseau V; Despas F; Montastruc JL; Olivier P
    Pharmaceut Med; 2019 Feb; 33(1):21-27. PubMed ID: 31933265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
    Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
    Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.
    McLernon DJ; Bond CM; Hannaford PC; Watson MC; Lee AJ; Hazell L; Avery A;
    Drug Saf; 2010 Sep; 33(9):775-88. PubMed ID: 20701410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent Adverse Drug Reactions, and Medication Groups under Suspicion.
    Dubrall D; Schmid M; Alešik E; Paeschke N; Stingl J; Sachs B
    Dtsch Arztebl Int; 2018 Jun; 115(23):393-400. PubMed ID: 29960607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic-Related Adverse Drug Reactions at a Tertiary Care Hospital in South Korea.
    Jung IY; Kim JJ; Lee SJ; Kim J; Seong H; Jeong W; Choi H; Jeong SJ; Ku NS; Han SH; Choi JY; Song YG; Park JW; Kim JM
    Biomed Res Int; 2017; 2017():4304973. PubMed ID: 29457026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of References in Responses from Scandinavian Drug Information Centres.
    Schjøtt J; Böttiger Y; Damkier P; Reppe LA; Kampmann JP; Christensen HR; Spigset O
    Medicines (Basel); 2018 Jul; 5(3):. PubMed ID: 29966383
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study.
    Chan SL; Ang X; Sani LL; Ng HY; Winther MD; Liu JJ; Brunham LR; Chan A
    Br J Clin Pharmacol; 2016 Dec; 82(6):1636-1646. PubMed ID: 27640819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ontological Organization and Bioinformatic Analysis of Adverse Drug Reactions From Package Inserts: Development and Usability Study.
    Li X; Lin X; Ren H; Guo J
    J Med Internet Res; 2020 Jul; 22(7):e20443. PubMed ID: 32706718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China.
    Qing-ping S; Xiao-dong J; Feng D; Yan L; Mei-ling Y; Jin-xiu Z; Shu-qiang Z
    BMC Health Serv Res; 2014 Feb; 14():73. PubMed ID: 24533894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China.
    Zhao Z; Shen J; Shen C; Zhu B; Sun J; Yu J; Sun F; Song H
    Curr Med Res Opin; 2021 Nov; 37(11):2001-2006. PubMed ID: 34376068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse Drug Reactions in a Tertiary Care Emergency Medicine Ward - Prevalence, Preventability and Reporting.
    Rydberg DM; Holm L; Engqvist I; Fryckstedt J; Lindh JD; Stiller CO; Asker-Hagelberg C
    PLoS One; 2016; 11(9):e0162948. PubMed ID: 27622270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation and appraisal of drug information services in a rural secondary level care hospital, Anantapur, AP.
    Bhavsar R; Zachariah S; Thomas D; Kannan SM
    J Pharm Bioallied Sci; 2012 Oct; 4(4):302-6. PubMed ID: 23248563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug information center as referral service in a South Indian tertiary care hospital.
    Behera SK; Xavier AS; Gunaseelan V; Ravindra BK; Selvarajan S; Chandrasekaran A; Dkhar SA
    Int J Pharm Investig; 2017; 7(4):182-187. PubMed ID: 29692977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
    Aagaard L; Weber CB; Hansen EH
    Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.
    Mahadevappa M; Meher C; Pushpa NB; Kulkarni P; Poornima KS; Desai N
    Indian J Med Res; 2022 Jul; 156(1):111-121. PubMed ID: 36510903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital.
    Lee JE; Min KR; Kim SH; Kim AH; Kim ST
    Yonsei Med J; 2020 Oct; 61(10):875-879. PubMed ID: 32975062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions.
    Crescioli G; Brilli V; Lanzi C; Burgalassi A; Ieri A; Bonaiuti R; Romano E; Innocenti R; Mannaioni G; Vannacci A; Lombardi N
    Intern Emerg Med; 2021 Apr; 16(3):697-710. PubMed ID: 33355896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.